Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: A double‐blind randomized controlled trial
Open Access
- 20 August 2024
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (12) , 4167-4172
Abstract
Background: There is still no certain effective treatment for vitiligo as a common chronic skin disorder characterized by depigmented patches and loss of skin melanocytes. Objectives: This study evaluates the efficacy of oral silymarin combined with hair follicle transplantation compared to follicle transplantation alone in the treatment of refractory vitiligo. Materials and Methods: Twenty refractory vitiligo patients were enrolled in this randomized controlled clinical trial, following up for 3 months. One group underwent hair transplantation plus oral silymarin, while the other group underwent follicle transplantation alone. We assessed the progress with Vitiligo Extent Tensity Index ( VETI ) in both groups and the peri‐follicular pigmentation diameter was estimated monthly. The Friedman test for comparing two groups at the end and the Mann–Whitney test for comparing two groups during each month was used. Results: The mean age was 30.22 (18–59) years, with the male to female ratio of 1:1. The decrease in the VETI and increase in the perifollicular pigmentation was statistically significant between silymarin and another group in monthly follow‐up ( p ‐value: 0.019, 0.019, and 0.035, respectively). Finally, the re‐pigmentation was notable in silymarin group ( p ‐value p ‐value: 0.012 and 0.044, respectively); although the improvement was not statistically significant between genders in each month. Conclusion: According to our study, silymarin in combination with hair transplantation could be a potential medical treatment for vitiligo; however, further trials are needed to establish the efficacy of combination therapies.Keywords
This publication has 24 references indexed in Scilit:
- Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy aloneJournal of Dermatological Treatment, 2019
- Interventions for VitiligoJAMA, 2016
- VitiligoThe Lancet, 2015
- A comparative study of the mini-punch grafting and hair follicle transplantation in the treatment of refractory and stable vitiligoJournal of the American Academy of Dermatology, 2014
- Current remedies for vitiligoAutoimmunity Reviews, 2010
- Identification of hepatoprotective flavonolignans from silymarinProceedings of the National Academy of Sciences of the United States of America, 2010
- The burden of vitiligo: Patient characteristics associated with quality of lifeJournal of the American Academy of Dermatology, 2009
- Silymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injuryBurns, 2007
- Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitisArchives of Pharmacal Research, 2007
- Glycogen Synthase Kinase 3β Is Activated by cAMP and Plays an Active Role in the Regulation of MelanogenesisJournal of Biological Chemistry, 2002